Highly specific functional equivalence of XN-HPC for optimum CD34+ cell count in harvested allogeneic bone marrow stem cell products

References

• National institute of health (NIH). The stem cell information Stem Cell Basics. [Online]. [cited 2018 Oct 3]. Available from: https://stemcells.nih.gov/info/basics.htm.
   Google Scholar
• Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009 Mar;24(2):98.
   PubMed Web of Science ®Google Scholar
• Nadig RR. Stem cell therapy–hype or hope? A review. J Conserv Dent. 2009 Oct;12(4):131.
   PubMedGoogle Scholar
• Bajada S, Mazakova I, Richardson JB, et al. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med. 2008 Jun;2(4):169–183.
   PubMed Web of Science ®Google Scholar
• Good RA, Meuwissen HJ, Hong R, et al. Bone marrow transplantation: correction of immune deficit in lymphopenic immunologic deficiency and correction of an immunologically induced pancytopenia. Trans Assoc Am Physicians. 1969;82:278.
   PubMedGoogle Scholar
• Eapen M, Le Rademacher J, Antin JH, et al. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood. 2011 Sep 1;118(9):2618–2621.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Socié G, Schrezenmeier H, et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 2012 Aug 1;97(8):1142–1148.
   PubMed Web of Science ®Google Scholar
• de Latour R P, Porcher R, Dalle JH, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow transplantation experience. Blood. J Am Soc Hematol. 2013 Dec 19;122(26):4279–4286.
   Google Scholar
• Abutalib SA. Clinical manual of blood and bone marrow transplantation [Internet]. Abutalib SA, Hari P, editors. Nashville (TN): John Wiley & Sons; 2017. doi:10.1002/9781119095491.
   Google Scholar
• Peerschke EI, Moung C, Pessin MS, et al. Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections. Transfusion. 2015;55(8):2001–2009.
   PubMed Web of Science ®Google Scholar
• Bender JG, To LB, Williams S, et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother. 1992;1(4):329–341.
   PubMedGoogle Scholar
• Hequet O. Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility. J Blood Med. 2015;18(6):55–67.
   Google Scholar
• To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood. 1997;89(7):2233–2258.
   PubMed Web of Science ®Google Scholar
• D'Rozario J, Parisotto R, Stapleton J, et al. Pre infusion, post thaw CD34 + peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation. Transfus Apher Sci. 2014;50(3):443–450.
   PubMed Web of Science ®Google Scholar
• ChinYee I, Anderson L, Keeney M, et al. Quality assurance of stem cell enumeration by flow cytometry. Cytom: J Int Soc Anal Cytol. 1997;30(6):296–303.
   PubMedGoogle Scholar
• Fritsch G, Printz D, Stimpfl M, et al. Quantification of CD34 + cells: comparison of methods. Transfusion. 1997;37(8):775–784.
   PubMed Web of Science ®Google Scholar
• Gratama JW, Orfao A, Barnett D, et al. Flow cytometric enumeration of CD34 + hematopoietic stem and progenitor cells. Cytometry. 1998;34(3):128–142.
   PubMedGoogle Scholar
• Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol. 1996;14(3):970–973.
   PubMed Web of Science ®Google Scholar
• Fatorova I, Blaha M, Lanska M, et al. Timing of peripheral blood stem cell yield: comparison of alternative methods with the classic method for CD34 cell determination. Bio Med Res Int. 2014;2014:1–13.
   Google Scholar
• Kikuchi-Taura A, Soma T, Matsuyama T, et al. A new protocol for quantifying CD34 + cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J. 2006;33(4):427–429.
   PubMedGoogle Scholar
• Keeney M, Chin-Yee I, Weir K, et al. Single platform flow cytometric absolute CD34 + cell counts based on the ISHAGE guidelines. Cytom: J Int Soc Anal Cytol. 1998 Apr 15;34(2):61–70.
   PubMedGoogle Scholar
• Sutherland DR, Stewart AK, Keating A. CD34 antigen: molecular features and potential clinical applications. Stem Cells. 1993;11(S3):50–57.
   PubMedGoogle Scholar
• Sutherland DR, Keeney M, Gratama JW. Enumeration of CD34 + hematopoietic stem and progenitor cells. Curr Protoc Cytom. 2003;25(1):6–4.
   Google Scholar
• Letestu R, Marzac C, Audat F, et al. Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring. Leuk Lymphoma. 2007;48(1):89–96.
   PubMed Web of Science ®Google Scholar
• Zulkafli Z, Mustaffa R, Yusoff SM. Hematopoietic progenitor cells as a predictive of CD34 + enumeration prior to peripheral blood stem cells harvesting. Bali Med J. 2014;3(3):112–115.
   Google Scholar
• Oelschlaegel U, Bornhaeuser M, Thiede C, et al. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34 + measurements and timing of leukaphereses. Cytotherapy. 2003;5(5):414–419.
   PubMed Web of Science ®Google Scholar
• Park KU, Kim SH, Suh C, et al. Correlation of hematopoietic progenitor cell count determined by the SE-9000™ automated hematology analyzer with CD34 + cell count by flow cytometry in leukapheresis products. Am J Hematol. 2001;67(1):42–47.
   PubMed Web of Science ®Google Scholar
• Steussy BW, Capper M, Krasowski MD, et al. Algorithms utilizing peripheral blood hematopoietic progenitor cell counts in lieu of some CD34 + cell counts predict successful peripheral blood stem cell collections with substantial time and cost savings. ISBT Sci Ser. 2016;11(3):153–162.
   PubMedGoogle Scholar
• Yamane T, Takekawa K, Tatsumi N. Possibility of identification of hematopoietic stem cells using a conventional blood cell counter. Eur J Haematol. 1995;55(3):207–208.
   PubMed Web of Science ®Google Scholar
• Takekawa K Y, Suzuki K, Hino M, et al. Identification of hematopoietic stem cells by the SE-9000™ automated hematology analyzer in peripheral blood stem cell harvest samples. Acta Haematol. 1997;98:54–55..
   PubMed Web of Science ®Google Scholar
• Mishra S, Kulkarni U, Mathews N, et al. PB2388 a study to compare hpc determined on the sysmex xn-9000 with flowcytometric cd34 count in peripheral blood and in the harvested peripheral blood stem cell graft from autologous and allogenic donors. HemaSphere. 2019 Jun 1;3(S1):1062.
   Google Scholar
• Dima FB, Midolo M, Benedetti F, et al. Assessment of haematopoietic progenitor cell counting with the sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells. Blood Transfus. 2019 Jul 25;1:1–9.
   Google Scholar
• Peerschke EI, Moung C, Pessin MS, et al. Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections. Transfusion. 2015 Aug;55(8):2001–2009.
   PubMed Web of Science ®Google Scholar
• Jamal A, Khan MT, Parveen S, et al. Peripheral blood stem cell harvest HPC count Is an effective surrogate marker for CD34+ cell count in allogeneic stem cell transplant setting. Transl Oncol. 2020 Jul 1;13(7):100788.
   PubMed Web of Science ®Google Scholar
• Shaw BE, Logan BR, Spellman SR, et al. Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most. Biol Blood Marrow Transplant. 2018 May 1;24(5):1049–1056.
   PubMed Web of Science ®Google Scholar
• Kollman C, Spellman SR, Zhang MJ, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood, J Am Soc Hematol. 2016 Jan 14;127(2):260–267.
   Google Scholar
• Ayuk F, Zabelina T, Wortmann F, et al. Donor choice according to age for allo-SCT for AML in complete remission. Bone Marrow Transplant. 2013 Aug;48(8):1028–1032.
   PubMed Web of Science ®Google Scholar
• Anderlini P. Sixty as the new forty: considerations on older related stem cell donors. Bone Marrow Transplant. 2017 Jan;52(1):15–19.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014 Dec 25;371(26):2488–2498.
   PubMed Web of Science ®Google Scholar